THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY)
Aim. To evaluate the differences between a group of patients treated with ursodeoxycholic acid (UDCA) during the study period and a group of patients not treated with UDCA by pseudo-randomization using Propensity Score Matching.Material and methods. 262 patients aged 60.1±8.9 years, taking statins f...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-09-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/95 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849228034277638144 |
|---|---|
| author | N. P. Kutishenko S. Yu. Martsevich O. V. Lerman I. S. Balashov V. A. Nevzorova I. I. Reznik G. V. Shavkuta D. A. Yakhontov |
| author_facet | N. P. Kutishenko S. Yu. Martsevich O. V. Lerman I. S. Balashov V. A. Nevzorova I. I. Reznik G. V. Shavkuta D. A. Yakhontov |
| author_sort | N. P. Kutishenko |
| collection | DOAJ |
| description | Aim. To evaluate the differences between a group of patients treated with ursodeoxycholic acid (UDCA) during the study period and a group of patients not treated with UDCA by pseudo-randomization using Propensity Score Matching.Material and methods. 262 patients aged 60.1±8.9 years, taking statins for the secondary prevention of cardiovascular complications were included into a 6-month observational cohort study. The UDCA intake was recommended to all the patients due to the presence of liver and/or bile duct diseases. One part of the patients strictly followed medical recommendations and used UDCA, while the other part of the patients wasn’t taking UDCA. This allowed comparing the effect of UDCA in these groups.Results. Propensity Score Matching method allowed forming two groups of patients of 52 people each with similar main clinical and demographic characteristics. A more significant decrease in the levels of total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C) (up to 4.0 mmol/L and 1.92 mmol/L, respectively; p<0.001) after 6 months was found in patients treated with lipid-lowering therapy in combination with UDCA as compared with patients without UDCA (up to 4.52 mmol/L and 2.6 mmol/L, respectively; p<0.05). No ALT, AST, CPK, LDH activity deterioration and no bilirubin serum level increase was found. Due to statin treatment the target levels of LDL-C by the end of the study were achieved in 31% of the patients of UDCA-group. Target levels of LDL-C were not achieved in any of the patients of the group without UDCA (p<0.001). There was demonstrated a high adherence to UDCA therapy.Conclusion. Combined therapy with statins and UDCA is effective and safe in patients with high cardiovascular risk and concomitant liver disease. Co-administration of statins with UDCA is promising in the treatment of hyperlipidemia in patients with low tolerance to statins. However, additional controlled studies are required. |
| format | Article |
| id | doaj-art-9ec3f2f720fe42ab89f3a2cc2e7c9814 |
| institution | Kabale University |
| issn | 1819-6446 2225-3653 |
| language | English |
| publishDate | 2015-09-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj-art-9ec3f2f720fe42ab89f3a2cc2e7c98142025-08-23T10:00:16ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-09-0111329730310.20996/1819-6446-2015-11-3-297-30394THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY)N. P. Kutishenko0S. Yu. Martsevich1O. V. Lerman2I. S. Balashov3V. A. Nevzorova4I. I. Reznik5G. V. Shavkuta6D. A. Yakhontov7State Research Centre for Preventive MedicineState Research Centre for Preventive MedicineState Research Centre for Preventive MedicineState Research Centre for Preventive Medicine, I.M. Sechenov First Moscow State Medical UniversityVladivostok State Medical UniversityUral State Medical AcademyRostov State Medical UniversityNovosibirsk State Medical UniversityAim. To evaluate the differences between a group of patients treated with ursodeoxycholic acid (UDCA) during the study period and a group of patients not treated with UDCA by pseudo-randomization using Propensity Score Matching.Material and methods. 262 patients aged 60.1±8.9 years, taking statins for the secondary prevention of cardiovascular complications were included into a 6-month observational cohort study. The UDCA intake was recommended to all the patients due to the presence of liver and/or bile duct diseases. One part of the patients strictly followed medical recommendations and used UDCA, while the other part of the patients wasn’t taking UDCA. This allowed comparing the effect of UDCA in these groups.Results. Propensity Score Matching method allowed forming two groups of patients of 52 people each with similar main clinical and demographic characteristics. A more significant decrease in the levels of total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C) (up to 4.0 mmol/L and 1.92 mmol/L, respectively; p<0.001) after 6 months was found in patients treated with lipid-lowering therapy in combination with UDCA as compared with patients without UDCA (up to 4.52 mmol/L and 2.6 mmol/L, respectively; p<0.05). No ALT, AST, CPK, LDH activity deterioration and no bilirubin serum level increase was found. Due to statin treatment the target levels of LDL-C by the end of the study were achieved in 31% of the patients of UDCA-group. Target levels of LDL-C were not achieved in any of the patients of the group without UDCA (p<0.001). There was demonstrated a high adherence to UDCA therapy.Conclusion. Combined therapy with statins and UDCA is effective and safe in patients with high cardiovascular risk and concomitant liver disease. Co-administration of statins with UDCA is promising in the treatment of hyperlipidemia in patients with low tolerance to statins. However, additional controlled studies are required.https://www.rpcardio.online/jour/article/view/95dyslipidemiahigh cardiovascular riskstatinsliver disordersursodeoxycholic acidsafety of the therapypropensity score matching analysis |
| spellingShingle | N. P. Kutishenko S. Yu. Martsevich O. V. Lerman I. S. Balashov V. A. Nevzorova I. I. Reznik G. V. Shavkuta D. A. Yakhontov THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) Рациональная фармакотерапия в кардиологии dyslipidemia high cardiovascular risk statins liver disorders ursodeoxycholic acid safety of the therapy propensity score matching analysis |
| title | THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) |
| title_full | THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) |
| title_fullStr | THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) |
| title_full_unstemmed | THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) |
| title_short | THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) |
| title_sort | improvement of lipid lowering therapy effectiveness in patients with high cardiovascular risk and concomitant liver disease results of additional analysis of the rakurs study |
| topic | dyslipidemia high cardiovascular risk statins liver disorders ursodeoxycholic acid safety of the therapy propensity score matching analysis |
| url | https://www.rpcardio.online/jour/article/view/95 |
| work_keys_str_mv | AT npkutishenko theimprovementoflipidloweringtherapyeffectivenessinpatientswithhighcardiovascularriskandconcomitantliverdiseaseresultsofadditionalanalysisoftherakursstudy AT syumartsevich theimprovementoflipidloweringtherapyeffectivenessinpatientswithhighcardiovascularriskandconcomitantliverdiseaseresultsofadditionalanalysisoftherakursstudy AT ovlerman theimprovementoflipidloweringtherapyeffectivenessinpatientswithhighcardiovascularriskandconcomitantliverdiseaseresultsofadditionalanalysisoftherakursstudy AT isbalashov theimprovementoflipidloweringtherapyeffectivenessinpatientswithhighcardiovascularriskandconcomitantliverdiseaseresultsofadditionalanalysisoftherakursstudy AT vanevzorova theimprovementoflipidloweringtherapyeffectivenessinpatientswithhighcardiovascularriskandconcomitantliverdiseaseresultsofadditionalanalysisoftherakursstudy AT iireznik theimprovementoflipidloweringtherapyeffectivenessinpatientswithhighcardiovascularriskandconcomitantliverdiseaseresultsofadditionalanalysisoftherakursstudy AT gvshavkuta theimprovementoflipidloweringtherapyeffectivenessinpatientswithhighcardiovascularriskandconcomitantliverdiseaseresultsofadditionalanalysisoftherakursstudy AT dayakhontov theimprovementoflipidloweringtherapyeffectivenessinpatientswithhighcardiovascularriskandconcomitantliverdiseaseresultsofadditionalanalysisoftherakursstudy AT npkutishenko improvementoflipidloweringtherapyeffectivenessinpatientswithhighcardiovascularriskandconcomitantliverdiseaseresultsofadditionalanalysisoftherakursstudy AT syumartsevich improvementoflipidloweringtherapyeffectivenessinpatientswithhighcardiovascularriskandconcomitantliverdiseaseresultsofadditionalanalysisoftherakursstudy AT ovlerman improvementoflipidloweringtherapyeffectivenessinpatientswithhighcardiovascularriskandconcomitantliverdiseaseresultsofadditionalanalysisoftherakursstudy AT isbalashov improvementoflipidloweringtherapyeffectivenessinpatientswithhighcardiovascularriskandconcomitantliverdiseaseresultsofadditionalanalysisoftherakursstudy AT vanevzorova improvementoflipidloweringtherapyeffectivenessinpatientswithhighcardiovascularriskandconcomitantliverdiseaseresultsofadditionalanalysisoftherakursstudy AT iireznik improvementoflipidloweringtherapyeffectivenessinpatientswithhighcardiovascularriskandconcomitantliverdiseaseresultsofadditionalanalysisoftherakursstudy AT gvshavkuta improvementoflipidloweringtherapyeffectivenessinpatientswithhighcardiovascularriskandconcomitantliverdiseaseresultsofadditionalanalysisoftherakursstudy AT dayakhontov improvementoflipidloweringtherapyeffectivenessinpatientswithhighcardiovascularriskandconcomitantliverdiseaseresultsofadditionalanalysisoftherakursstudy |